QCTR is a niche CRO specialising in psychiatry and neurology.

We provide clinical trial management, as well as medical writing and regulatory advice services to the pharmaceutical industry.

We have over 10 years’ experience in conducting clinical trials in psychiatry and neurology, including conditions such as depression, schizophrenia, multiple sclerosis, Huntington’s disease and Parkinson's disease. We have worked

closely with the leading experts in these diseases and with leading centres of excellence around the world. We also have a wealth of regulatory experience having attended meetings and presented data at the US Food and Drug Administration (FDA) and European Medicines Evaluation Agency (EMEA).